Similar articles for PMID: 21349969

Year	Number of Results
1998	1
2001	1
2003	1
2005	2
2006	3
2008	1
2009	5
2010	6
2011	10
2012	9
2013	7
2014	10
2015	20
2016	16
2017	14
2018	9
2019	1
2020	3
2021	2
2024	0

1

Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Chawla S, Kim S, Loevner LA, Hwang WT, Weinstein G, Chalian A, Quon H, Poptani H. Chawla S, et al. AJNR Am J Neuroradiol. 2011 Apr;32(4):778-84. doi: 10.3174/ajnr.A2376. Epub 2011 Feb 24. AJNR Am J Neuroradiol. 2011. PMID: 21349969 Free PMC article.

2

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S, Wang Y, Kraus D, Shah JP, Pfister DG, Koutcher JA. Shukla-Dave A, et al. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006. Epub 2011 May 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 21601373 Free PMC article.

3

Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, Chalian A, Poptani H. Kim S, et al. AJNR Am J Neuroradiol. 2010 Feb;31(2):262-8. doi: 10.3174/ajnr.A1817. Epub 2009 Oct 1. AJNR Am J Neuroradiol. 2010. PMID: 19797785 Free PMC article. Clinical Trial.

4

Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τ _i ): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas.

Chawla S, Loevner LA, Kim SG, Hwang WT, Wang S, Verma G, Mohan S, LiVolsi V, Quon H, Poptani H. Chawla S, et al. AJNR Am J Neuroradiol. 2018 Jan;39(1):138-144. doi: 10.3174/ajnr.A5440. Epub 2017 Nov 16. AJNR Am J Neuroradiol. 2018. PMID: 29146716 Free PMC article.

5

Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.

Jansen JF, Schöder H, Lee NY, Stambuk HE, Wang Y, Fury MG, Patel SG, Pfister DG, Shah JP, Koutcher JA, Shukla-Dave A. Jansen JF, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):299-307. doi: 10.1016/j.ijrobp.2010.11.022. Epub 2011 Jan 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 21236594 Free PMC article.

6

Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.

Chawla S, Kim S, Dougherty L, Wang S, Loevner LA, Quon H, Poptani H. Chawla S, et al. AJR Am J Roentgenol. 2013 Jan;200(1):35-43. doi: 10.2214/AJR.12.9432. AJR Am J Roentgenol. 2013. PMID: 23255739 Free PMC article.

7

Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer.

Baer AH, Hoff BA, Srinivasan A, Galbán CJ, Mukherji SK. Baer AH, et al. AJNR Am J Neuroradiol. 2015 Apr;36(4):757-62. doi: 10.3174/ajnr.A4296. Epub 2015 Mar 19. AJNR Am J Neuroradiol. 2015. PMID: 25792532 Free PMC article.

8

Dynamic contrast-enhanced MRI, diffusion-weighted MRI and ¹⁸F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.

Ng SH, Liao CT, Lin CY, Chan SC, Lin YC, Yen TC, Chang JT, Ko SF, Fan KH, Wang HM, Yang LY, Wang JJ. Ng SH, et al. Eur Radiol. 2016 Nov;26(11):4162-4172. doi: 10.1007/s00330-016-4276-8. Epub 2016 Feb 24. Eur Radiol. 2016. PMID: 26911889

9

Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.

Amsbaugh MJ, Yusuf M, Gaskins J, Silverman C, Potts K, Bumpous J, Redman R, Perez C, Dunlap N. Amsbaugh MJ, et al. Am J Otolaryngol. 2017 Sep-Oct;38(5):588-592. doi: 10.1016/j.amjoto.2017.06.006. Epub 2017 Jun 14. Am J Otolaryngol. 2017. PMID: 28633765

10

Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.

Inokuchi H, Kodaira T, Tachibana H, Nakamura T, Tomita N, Nakahara R, Takada A, Mizoguchi N, Tamaki T, Fuwa N. Inokuchi H, et al. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):747-55. doi: 10.1016/j.ijrobp.2009.11.034. Epub 2010 Apr 29. Int J Radiat Oncol Biol Phys. 2011. PMID: 20434274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year